@article{1803b7fe970f4ae4a8136a8bd2029df7,
title = "Correspondence to letter to the editor on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial”",
keywords = "Biomarkers, Hepatocellular carcinoma, Immunotherapy, Liver cancer",
author = "Lee, {Sung Hwan} and Yim, {Sun Young} and Kim, {Ji Hoon} and Lee, {Sunyoung S.} and Kaseb, {Ahmed O.} and Peng Wei and Lee, {Ju Seog}",
year = "2025",
month = jan,
doi = "10.3350/CMH.2024.0828",
language = "English (US)",
volume = "31",
pages = "e110--e112",
journal = "Clinical and Molecular Hepatology",
issn = "2287-2728",
publisher = "Korean Association for the Study of the Liver",
number = "1",
}